Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001054940 | SCV001219299 | uncertain significance | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14; Autosomal recessive limb-girdle muscular dystrophy type 2T | 2022-07-05 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 261 of the GMPPB protein (p.Arg261Cys). This variant is present in population databases (rs746357591, gnomAD 0.004%). This missense change has been observed in individual(s) with congenital myasthenic syndrome (PMID: 26133662). ClinVar contains an entry for this variant (Variation ID: 850712). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GMPPB protein function. Experimental studies have shown that this missense change affects GMPPB function (PMID: 31211170). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV003106106 | SCV003761838 | likely pathogenic | not provided | 2022-07-27 | criteria provided, single submitter | clinical testing | Published functional studies suggest a damaging effect (partial decrease of enzymatic activity with no demonstrated phenotypic effect on the animal model) (Liu et al., 2021); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31211170, 26133662, 35006422) |
Revvity Omics, |
RCV003106106 | SCV003816952 | uncertain significance | not provided | 2024-01-02 | criteria provided, single submitter | clinical testing |